Therefore, in RCC cells, ZNF677 binds to the promoter of its target CDKN3 to regulate cellular activities, and is modified through an m6A‐dependent turnover mechanism by interacting with the m6A readers IGF2BP2 and YTHDF1. Here, ZNF677 is linked to renal cell carcinoma.